Skip to content

Clinical trials

Phase 2 Acute Chest Syndrome trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Acute Chest Syndrome Phase: Phase 2 Country / region: United States Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20111
20141
20181
20201
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Anthera Pharmaceuticals1
CSL Behring1
Columbia University1
Craig Seaman1
Gary M Brittenham, MD1
New York Medical College1
St. Jude Children's Research Hospital1
University of Chicago1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Acute Chest Syndrome8
Anemia, Sickle Cell8
Vaso-Occlusive Crises3
Asthma2
Respiratory Tract Infections2
Vitamin D Deficiency2
Acute Kidney Injury1
Anemia, Hemolytic1
Anemia, Hemolytic, Congenital1
Avitaminosis1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.